Enjoy complimentary customisation on priority with our Enterprise License!
The global preimplantation genetic diagnosis market size has the potential to grow by USD 131.99 million during 2019-2023, and the market’s growth momentum will accelerate throughout the forecast period because of the steady increase in the year-over-year growth.
This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW) and end-users (fertility clinics and maternity centers, hospitals and diagnostic laboratories, and research institutes). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Genea Ltd., Igenomix Sl, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, Natera Inc., Oxford Gene Technology Group, PerkinElmer Inc., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.
Browse TOC and LoE with selected illustrations and example pages of preimplantation genetic diagnosis market
The market is concentrated, and the degree of concentration will decrease during the forecast period. The key players in the market are focusing on various growth strategies such as mergers and acquisitions, divestitures, joint ventures, and partnerships to expand the geographical reach and gain major market shares and revenue. PerkinElmer Inc., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc. are a few of the major market participants. Although the accelerating growth momentum will offer immense growth opportunities, concerns about safety and privacy of genetic data will challenge the growth of market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market positions, this preimplantation genetic diagnosis market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this preimplantation genetic diagnosis market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading preimplantation genetic diagnosis companies, including:
For more insights on the preimplantation genetic diagnosis market share of various regions Request for a FREE sample now!
North America was the largest market for preimplantation genetic diagnosis in 2018, and the region will continue to offer maximum growth opportunities to market vendors during the forecast period. The increasing use of PGD for sex selection and early diagnosis of heritable disorders and diseases will contribute to the preimplantation genetic diagnosis market growth in the region.
Over 35% of the market’s growth will originate from North America during the forecast period. The US, Mexico, and Canada are the key markets of preimplantation genetic diagnosis in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.
Request for a FREE sample and Get more information on the market contribution of various end-users
A significant number of IVF cycles are performed in fertility clinics and maternity centers because of the promising success rates of fertility treatments. PGD is an integral part of IVF and is highly recommended to patients who have a history of genetic disorders, and fertility clinics and maternity centers are among the prime consumers of PGD products. Therefore, the demand for PGD testing to increase the chances of successful IVF pregnancies in couples with prior unexplainable IVF failures has driven the global PGD market growth by the fertility clinics and maternity centers segment.
Moreover, market growth by the fertility clinics and maternity centers segment will be faster than the development of the market by the hospitals and diagnostic laboratories and research institutes segments. This report provides an accurate prediction of the contribution of all the segments to the growth of the preimplantation genetic diagnosis market size.
The growing demand for improved healthcare services and rising disposable income are creating a scope for the development of advanced diagnostic and treatment techniques. Early diagnostic techniques, during genetic IVF techniques and other artificial insemination procedures, have gained prominence in the healthcare sector because of the rising need to prevent physical disabilities and health conditions in new-borns. Preimplantation diagnostic tests can determine genetic disorders, such as cystic fibrosis, congenital hearing loss, and thalassemia, by diagnosing genetic variations at the embryonic stage. Moreover, governments and non-profit organizations are taking initiatives to spread awareness about the benefits of early diagnosis of genetic disorders to promote the well-being of women and children. These factors are fueling the preimplantation genetic diagnosis market growth over the forecast period.
Request for a FREE sample now!
We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY END-USER
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.